Rising demand for gene and cell therapies, expanding mRNA vaccine pipelines, and increasing investments in GMP-compliant manufacturing facilities are driving growth in the viral vectors and plasmid ...
Linde EPS growth from pricing and productivity, with AI and electronics upside; shares offer 20% 12-month upside and 1.5% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback